Carlos Chan | University of Iowa Clinical Research and Trials

Attention Site Visitor

You are currently visiting the UI Health Care Clinical Trials website on a version of the web browser: Internet Explorer. Internet Explorer is no longer being supported by Microsoft, and there are features and functionality on this website that does not operate properly when using Internet Explorer. If you have an alternative browser, such as: Microsoft Edge, Google Chrome, Mozilla Firefox, or Apple Safari, we suggest you switch to that browser for the optimal viewing experience.

Thank you

Studies

Protocol EA2185: Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Cancer Pancreas Adult Subjects

Phase I trial of intraperitoneal paclitaxel-loaded tumor penetrating microparticles (TPM) for treatment of peritoneal carcinomatosis

Cancer Adult Subjects Female Subjects Male Subjects

A first-in-human, unblinded, phase I trial of Paclitaxel-loaded tumor penetrating microparticles (TPM) in peritoneal carcinomatosis patients who are not eligible for standard-of-care therapeutic interventions.